CRISPR Therapeutics AG buy Saftman
Start price
20.12.23
/
50%
€41.40
Target price
20.12.24
-
Performance (%)
-
End price
31.01.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| CRISPR Therapeutics AG | - | - |
| iShares Core DAX® | -3.935% | -2.628% |
| iShares Nasdaq 100 | -3.608% | -9.283% |
| iShares Nikkei 225® | -4.513% | -6.951% |
| iShares S&P 500 | -2.607% | -4.402% |
Comments by Saftman for this prediction
In the thread CRISPR Therapeutics AG diskutieren
Saftman hat das Wertpapier CRISPR Therapeutics AG in seinem Wikifolio Langfristige Aufwärtstrends gekauft.